Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)

ISSN： 1010-4283

Source： Tumor Biology, Vol.31, Iss.5, 2010-10, pp. : 495-502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphisms in the MUC16 Gene: Potential Implication in Epithelial Ovarian Cancer

By Bouanene Houda

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 295-299

Springer Publishing Company

Access to resources Recommend Favorite

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

By Granato Teresa

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1335-1339

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T. Marth C. Kaern J. Nustad K. Kristensen G.B. Trope C.

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A. Nielsen D. Engelholm S.A.

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Serum CA-125 Screening for Ovarian Cancer in Patients with Dermatomyositis

By Whitmore S.E. Anhalt G.J. Provost T.T. Zacur H.A. Hamper U.M. Helzlsouer K.J. Rosenshein N.B.

Gynecologic Oncology, Vol. 65, Iss. 2, 1997-05 ,pp. : 241-244

Elsevier

Access to resources Recommend Favorite